Clinical Trial Update: Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of arotinolol hydrochloride on morning blood pressure and heart rate in essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Arotinolol hydrochloride (arotinolol hydrochloride)

Snippet

Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: Essential Hypertension | Phase 4 | Status: COMPLETED